Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE HealthCare
GEHC
|
+$484M |
| 2 |
Microsoft
MSFT
|
+$417M |
| 3 |
Amazon
AMZN
|
+$365M |
| 4 |
Apple
AAPL
|
+$357M |
| 5 |
Merck
MRK
|
+$311M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$420M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Philip Morris
PM
|
+$246M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$228M |
| 5 |
Meta Platforms (Facebook)
META
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.14% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Fulcrum Therapeutics
FULC
$288M
| $3.03M | ﹤0.01% |
1,062,634
+206,802
| +24% | +$1.85M |
|
2852
Ardagh Metal Packaging
AMBP
$3.04B
| $3.02M | ﹤0.01% |
739,991
+40,781
| +6% | +$200K |
|
2853
Wave Life Sciences
WVE
$1.17B
| $3M | ﹤0.01% |
692,802
+27,438
| +4% | +$126K |
|
2854
Bilibili
BILI
$7.78B
| $2.99M | ﹤0.01% |
127,321
+3,288
| +3% | +$78.2K |
|
2855
Scholar Rock
SRRK
$5.74B
| $2.99M | ﹤0.01% |
373,633
+10,397
| +3% | +$105K |
|
|
ZIMV
2856
DELISTED
ZimVie
ZIMV
| $2.99M | ﹤0.01% |
413,372
+19,425
| +5% | +$165K |
|
2857
AlTi Global
ALTI
$512M
| $2.99M | ﹤0.01% |
238,323
+222,537
| +1,410% | +$2.24M |
|
2858
Colony Bankcorp
CBAN
$470M
| $2.98M | ﹤0.01% |
292,555
+20,089
| +7% | +$244K |
|
2859
Heron Therapeutics
HRTX
$95.5M
| $2.98M | ﹤0.01% |
1,974,954
+16,512
| +0.8% | +$41.3K |
|
2860
Bausch Health
BHC
$2.35B
| $2.98M | ﹤0.01% |
309,264
-94,934
| -23% | -$762K |
|
2861
Blue Ridge Bankshares
BRBS
$330M
| $2.98M | ﹤0.01% |
292,050
+10,368
| +4% | +$123K |
|
|
SBDS
2862
DELISTED
Solo Brands Inc
SBDS
| $2.97M | ﹤0.01% |
10,343
+360
| +4% | +$69.3K |
|
2863
First Bank
FRBA
$455M
| $2.97M | ﹤0.01% |
293,841
+4,829
| +2% | +$62.3K |
|
2864
Fossil Group
FOSL
$349M
| $2.96M | ﹤0.01% |
926,343
+45,231
| +5% | +$203K |
|
2865
Prime Medicine
PRME
$556M
| $2.96M | ﹤0.01% |
240,345
+6,050
| +3% | +$98.6K |
|
2866
PepGen
PEPG
$137M
| $2.96M | ﹤0.01% |
241,707
+9,189
| +4% | +$144K |
|
2867
Global Water Resources
GWRS
$211M
| $2.96M | ﹤0.01% |
237,736
+15,251
| +7% | +$206K |
|
2868
Vale
VALE
$63.6B
| $2.95M | ﹤0.01% |
187,116
-3,236
| -2% | -$54.8K |
|
2869
Immersion
IMMR
$255M
| $2.94M | ﹤0.01% |
328,826
+16,441
| +5% | +$124K |
|
2870
Omeros
OMER
$916M
| $2.94M | ﹤0.01% |
631,892
+26,080
| +4% | +$94.1K |
|
2871
BRC Inc
BRCC
$253M
| $2.93M | ﹤0.01% |
570,749
+18,434
| +3% | +$116K |
|
|
ASRT
2872
DELISTED
Assertio
ASRT
| $2.92M | ﹤0.01% |
30,540
+2,225
| +8% | +$168K |
|
2873
Pearson
PSO
$10B
| $2.92M | ﹤0.01% |
279,229
-22,262
| -7% | -$241K |
|
|
THRX
2874
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $2.91M | ﹤0.01% |
327,870
+28,264
| +9% | +$277K |
|
2875
Alico
ALCO
$283M
| $2.9M | ﹤0.01% |
119,927
+12,603
| +12% | +$323K |
|
Similar funds
Geode Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Geode Capital Management held 4,968 positions worth $770B, up 8.1% from $713B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 4.6%. Geode Capital Management opened 69 new positions and exited 162, leaving the 4,968-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q1 2023 buy was GE HealthCare: 6,775,612 shares worth $554M.
- Geode Capital Management added most to Microsoft in Q1 2023, an estimated $417M increase.
- Geode Capital Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $420M.
- Geode Capital Management fully exited SVB Financial Group in Q1 2023, selling an estimated $288M.
- Geode Capital Management's ten largest holdings make up 23% of its $770B portfolio in Q1 2023.
- Geode Capital Management opened 69 new positions and closed 162 in Q1 2023.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $770B.
Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.